Skip to main content

Table 1 Study demographics of the AB128 study subjects a

From: Association between cell-bound blood amyloid-β(1 - 40) levels and hippocampus volume

  HC MCI AD
Number of subjects 49 33 14
Age (yr) 56.2 (5.6) 74.6 (6.4) 79.5 (5.3)
Education (% >8 yr) 94 33 64
Gender (% males) 26.5 27.3 28.6
ApoE (% ε4 allele) 64.3 57.6 64.3
Creatinine (mg/dl) 0.77 (0.11) 0.83 (0.2) 0.89 (0.27)
DA Aβ(1 - 40) (pg/ml) 38.9 (10.5) 58.1 (16.3) 50.3 (18.7)
TP Aβ(1 - 40) (pg/ml) 83.3 (18.0) 93.0 (16.3) 93.8 (19.5)
CP Aβ(1 - 40) (pg/ml) 58.0 (10.3) 55.0 (14.1) 64.4 (10.7)
DA Aβ(1 - 42) (pg/ml) 13.5 (14.8) 12.1 (15.0) 12.4 (9.4)
TP Aβ(1 - 42) (pg/ml) 52.2 (33.5) 49.7 (40.9) 55.8 (30.4)
CP Aβ(1 - 42) (pg/ml) 164.6 (77.0) 154.6 (71.1) 163.3 (54.5)
  1. aAD: Alzheimer’s disease; ApoE: Apolipoprotein E; Aβ: Amyloid- β CP: Cellular pellet; DA: Directly accessible; HC: Healthy control; MCI: Mild cognitive impairment; RP: Recovered from plasma; TP: Total in plasma. Mean value is the number reported and the standard deviation is in brackets, as applicable.